Uma Sinha Net Worth & Insider Trades

Uma Sinha - Chief Scientific Officer, Bridgebio Pharma, Inc

As of December 17, 2020

What is Uma Sinha's Net Worth?

The current estimated net worth of Bridgebio Pharma, Inc's Chief Scientific Officer, Uma Sinha, is estimated to be about $16.46M . Uma Sinha owns about 14,000 units of Bridgebio Pharma, Inc common stock. In the last year at Bridgebio Pharma, Inc, Uma Sinha has sold an estimated value of $0 worth.

What is Uma Sinha's Past Insider Trading?

Uma Sinha's largest purchase order was 14,000 units , worth over $238K on July 3, 2019. In total, Uma Sinha has made about 6 transactions over a year of their time at Bridgebio Pharma, Inc. Uma Sinha usually trades in June, July, August, December, November and May, with the busiest year in 2020.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Uma Sinha's Salary in 2020?

As Chief Scientific Officer of Bridgebio Pharma, Inc, Uma Sinha has a total base salary of $550,000 . Uma Sinha received compensation valued at about $10,054,909 in 2020 after becoming Chief Scientific Officer. The vast majority of their compensation came in the form of a bonus of $825,000 , stock awards of $2,368,511 , option awards of $6,299,998 , and other compensation of $11,400 .

What is Uma Sinha's' Mailing Address?

  • Mailing address is C/o Eidos Therapeutics, Inc. 101 Montgomery Street, Suite 2550 San Francisco CA 94101 CA

Bridgebio Pharma, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Compensation
Total
Neil Kumar, Ph.D. 2020 $550,000 $825,000 $2,368,511 $6,299,998 $11,400 $10,054,909
Neil Kumar, Ph.D. 2019 $502,765 $360,000 $13,863,445 $11,573,049 $34,804 $26,334,063
Neil Kumar, Ph.D. 2018 $450,000 - - - - $450,000
Brian Stephenson, Ph.D., CFA 2020 $550,000 $712,500 $789,494 $2,099,996 $11,943 $4,163,933
Brian Stephenson, Ph.D., CFA 2019 $420,000 $189,000 $132,600 $3,430,781 $26,586 $4,198,967
Brian Stephenson, Ph.D., CFA 2018 $74,375 $330,240 $1,942,500 - - $2,347,115
Michael Henderson, M.D. 2020 $515,000 $300,000 $7,072,500 $91,899 $11,843 $7,991,241
Cameron Turtle, Ph.D.* 2020 $400,000 $210,000 $3,940,081 - $11,400 $4,561,482
Charles Homcy, M.D. 2020 $500,000 $100,000 - $1,199,992 $55,812 $1,855,805
Charles Homcy, M.D. 2019 $513,808 - $2,111,579 $3,128,716 $221,737 $5,975,842
Brian Stolz 2020 $511,362 $25,000 $736,854 $1,992,182 $1,975,453 $5,240,851
Brian Stolz 2019 $146,780 $93,750 $6,860,780 $1,045,003 - $8,146,313
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1743881/000119312521145491/d131567ddef14a.htm

What are Bridgebio Pharma, Inc's Past Insider Trades?

Bridgebio Pharma, Inc's most recent insider trade came on March 17, 2022 by Andrea Ellis who bought 12,000 units worth $100.68K . In the last 3 years, insiders at Bridgebio Pharma, Inc have sold an estimated value of $352.17M and bought an estimated value of $213.34M worth of shares. Insider trading is most common in June, with the busiest year in 2020. The most active traders at the company are Neil Kumar, CEO and President,  Brian C Stephenson, Secretary,  and Thomas Michael Henderson, Chief Business Officer .

BridgeBio Pharma, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1